Company Jaguar Health, Inc.

Equities

JAGX

US47010C7065

Biotechnology & Medical Research

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sales per Business

Quarterly earnings - Rate of surprise

Sector Bio Therapeutic Drugs

Real-time Estimate Cboe BZX Other stock markets 12:32:13 2024-04-19 pm EDT			5-day change	1st Jan Change
0.169 ^USD	-4.57%		+86.49%	+11.23%

10:20am	Venture Life renews revolving credit facility with Santander and HSBC	AN
Apr. 10	Wall Street Set to Open Sharply Lower Wednesday as Inflation Rises More Than Expected	MT

Jaguar Health, Inc. is a commercial-stage pharmaceuticals company. The Company is focused on developing novel proprietary prescription medicines sustainably derived from plants from rainforest areas for people and animals with gastrointestinal distress. It operates through two segments: human health and animal health. The animal health segment is focused on developing and commercializing prescription and non-prescription products for companion and production animals. The human health segment is focused on developing and commercializing of human products and the ongoing commercialization of Mytesi, which is used for the symptomatic relief of non-infectious diarrhea in adults with human immunodeficiency virus (HIV)/ acquired immunodeficiency syndrome (AIDS) on antiretroviral therapy. The Canalevia-CA1 is for the treatment of chemotherapy-induced diarrhea (CID) in dogs. Its subsidiary Napo Pharmaceuticals, Inc. focuses on developing and commercializing human prescription pharmaceuticals.

Number of employees: 49

USD in Million	2022	Weight	2023	Weight	Delta
Human Health 98.2 %	12	98.2 %	10	98.2 %	-18.34%
Animal Health 1.8 %	0	1.8 %	0	1.8 %	-19.53%

USD in Million	2022	Weight	2023	Weight	Delta
United States 100.0 %	12	100.0 %	10	100.0 %	-18.36%

Managers	Title	Age	Since
Lisa Conte FOU	Founder	65	13-06-05
Carol Lizak DFI	Director of Finance/CFO	60	19-04-30
Pravin Ramsewak Chaturvedi CTO	Chief Tech/Sci/R&D Officer	60	17-04-30
Jonathan Wolin CMP	Compliance Officer	62	18-10-31
Darlene P. Horton CTO	Chief Tech/Sci/R&D Officer	62	21-04-30
Peter C. Hodge IRC	Investor Relations Contact	-	-
Karen Brunke PRN	Corporate Officer/Principal	72	21-09-08
Ian Wendt PRN	Corporate Officer/Principal	-	-
David Sesin PRN	Corporate Officer/Principal	-	-
Steven King PRN	Corporate Officer/Principal	66	03-12-31

Members of the board	Title	Age	Since
Lisa Conte FOU	Founder	65	13-06-05
James Bochnowski CHM	Chairman	80	14-01-31
John Micek BRD	Director/Board Member	71	16-03-31
Jonathan Siegel BRD	Director/Board Member	50	18-03-28
Anula Kusum Jayasuriya BRD	Director/Board Member	67	22-06-30

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	0	9	0	0	98.22 %
Stock B	1	276,216,260	271,298,602 ( 98.22 %)	0

Name	Equities	%	Valuation
Fife Trading, Inc. 2.358 %	4,875,000	2.358 %	438 750 $
Uptown Capital LLC 0.9231 %	1,908,651	0.9231 %	171 779 $
Fredrick Waid 0.9139 %	1,889,565	0.9139 %	170 061 $
Lisa Conte 0.1878 %	388,205	0.1878 %	34 938 $
Pravin Ramsewak Chaturvedi 0.0994 %	205,462	0.0994 %	18 492 $
Jonathan Wolin 0.0957 %	197,769	0.0957 %	17 799 $
Citadel Securities GP LLC 0.0935 %	193,330	0.0935 %	17 400 $
Vanguard Group, Inc. (Subfiler) 0.0930 %	192,335	0.0930 %	17 310 $
JPMorgan Securities LLC 0.0792 %	163,671	0.0792 %	14 730 $
Steven King 0.0775 %	160,311	0.0775 %	14 428 $

Jaguar Health, Inc.

200 Pine Street Suite 400

94104, San Francisco

http://www.jaguar.health

Company calendar

Healthcare

Pharmaceuticals & Medical Research

Biotechnology & Medical Research

Biotechnology & Medical Research

Bio Therapeutic Drugs

	1st Jan change	Capi.
JAGUAR HEALTH, INC.	+7.99%	48.92M
VERTEX PHARMACEUTICALS INCORPORATED	-2.68%	102B
REGENERON PHARMACEUTICALS, INC.	+2.03%	96.07B
ARGENX SE	-1.75%	21.66B
BIONTECH SE	-17.41%	20.77B
GENMAB A/S	-7.10%	18.53B
WUXI APPTEC CO., LTD.	-40.31%	16.91B
BEIGENE, LTD.	-28.14%	13.79B
NEUROCRINE BIOSCIENCES, INC.	+0.00%	13.33B
SAREPTA THERAPEUTICS, INC.	+20.29%	10.94B

Bio Therapeutic Drugs